These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10342830

  • 1. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
    Delbaere A, Sidis Y, Schneyer AL.
    Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
    [Abstract] [Full Text] [Related]

  • 2. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL.
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [Abstract] [Full Text] [Related]

  • 3. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
    Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
    [Abstract] [Full Text] [Related]

  • 4. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK, Lambert-Messerlian G, Zheng W, Crowley WF, Schneyer AL.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [Abstract] [Full Text] [Related]

  • 5. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
    Di Simone N, Hall HA, Welt C, Schneyer AL.
    Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
    [Abstract] [Full Text] [Related]

  • 6. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJ.
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [Abstract] [Full Text] [Related]

  • 7. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
    Bilezikjian LM, Corrigan AZ, Vaughan JM, Vale WM.
    Endocrinology; 1993 Dec; 133(6):2554-60. PubMed ID: 8243277
    [Abstract] [Full Text] [Related]

  • 8. [The regulation of gonadotropin receptor by the nonsteroidal intraovarian regulatory molecules during ovarian folliculogenesis].
    Minegishi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):751-62. PubMed ID: 7594884
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional activation of the gonadotropin-releasing hormone receptor gene by activin A.
    Fernández-Vázquez G, Kaiser UB, Albarracin CT, Chin WW.
    Mol Endocrinol; 1996 Apr; 10(4):356-66. PubMed ID: 8721981
    [Abstract] [Full Text] [Related]

  • 10. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL.
    Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
    [Abstract] [Full Text] [Related]

  • 11. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC, Gilrain JT, Bradshaw D, Myers CE.
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [Abstract] [Full Text] [Related]

  • 12. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
    Wang Q, Tabatabaei S, Planz B, Lin CW, Sluss PM.
    J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
    [Abstract] [Full Text] [Related]

  • 13. Regulation of follistatin production by rat granulosa cells in vitro.
    Shintani Y, Dyson M, Drummond AE, Findlay JK.
    Endocrinology; 1997 Jun; 138(6):2544-51. PubMed ID: 9165047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
    Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Sluss PM.
    Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
    [Abstract] [Full Text] [Related]

  • 19. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
    Dalkin AC, Haisenleder DJ, Yasin M, Gilrain JT, Marshall JC.
    Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
    [Abstract] [Full Text] [Related]

  • 20. Follistatin and its role as an activin-binding protein.
    Sugino H, Sugino K, Hashimoto O, Shoji H, Nakamura T.
    J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.